Q1 2019 Eloxx Pharmaceuticals Inc Earnings Call Transcript
Good morning, everyone, and welcome to Eloxx Pharmaceuticals' First Quarter 2019 Earnings Webcast and Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Barbara Ryan, Eloxx' Investor Relations Officer. Please begin.
Thank you, Liz. Welcome, and thank you for joining us this morning for a review of Eloxx Pharmaceuticals' first quarter 2019 financial results and business update. Joining me this morning are Robert Ward, Chairman and Chief Executive Officer; Dr. Greg Williams, our Chief Operating Officer; David Snow, Chief Business Officer; Dr. Susan Schneider, Senior Vice President, Clinical Development in Ophthalmology; and Greg Weaver, our Chief Financial Officer.
Before we begin, I'd like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |